|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers显示文摘 | Smith HL Karnes HT | 1990 | Prog Pharmacol Clin Pharmmol1990，8，： | 1 |
| 2 | Profiling in vitro drug re- lease from subcutaneous implants: a review of current status and potential implications on drug product development 显示文摘 | IYER SS BARR WH KARNES HT | 2006 | Biop- harm Drug Dispos2006，27，4： | 1 |
| 3 | A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine 显示文摘 | Chin C Zhang ZP Karnes HT | 2004 | J Pharm Biomed Anal2004，35，： | 1 |
| 4 | Precision, accuracy and data accep- tance criteria in biopharmaceutical analysis显示文摘 | Karnes HT March C | 1993 | Pharm Res1993，10，10： | 1 |
| 5 | A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable,naltrexone implant显示文摘 | Iyer SS Barr WH Karnes HT | 2007 | Int J Pharm2007，340，12： | 1 |
| 6 | Precision,accuracy and data acceptance criteria in biopharmaceutical analysis显示文摘 | Karnes HT Mardh C | 1993 | Pharm Res1993，10，： | 1 |
| 7 | Characterization of quinidine 3-hydroxylation as a probe for the CYP 3A enzyme using a novel capillary electrophoresis technique显示文摘 | Bhoopathy S Sarkar MA Karnes HT | 2002 | Eur J Pharm Sci2002，16，45： | 1 |
| 8 | Torasemide dose proportionality of pharmacokinetics and pharmacodynamics显示文摘 | Barr WH Smith HL Karnes HT | 1990 | Prog Pharmacol Clin Pharmacol1990，8，1： | 1 |
| 9 | Quantification of Alefacept, an immuno suppressive fusion protein in human plasma using a protein analogue internal standard, trypsin cleaved signature peptides and liquid chromatography tandem mass spectrometry 显示文摘 | Halquist MS Karnes HT | 2011 | J Chromatogr B2011，879，1112： | 1 |
| 10 | Characterization of quinidine 3-hydroxylation as a probe for the CYP 3A enzyme using a novel capillary electrophoresis technique显示文摘 | Sarkar MA Karnes HT | 2002 | Eur J Pharm Sci2002，16，45： | 1 |
| 11 | Coupling immunoassays with chromatographic separation techniques显示文摘 | Tang Z Karnes HT | 2000 | Biomed Chromatogr2000，14，6： | 1 |
| 12 | Recent developments in analytical methodology for 8-hydroxy-2'-deoxyguanosine and related compounds显示文摘 | Peoples MC Karnes HT | 2005 | J Chromatogr B Analyt Technol Biomed Life Sci2005，827，1： | 1 |
| 13 | Comparison of bioavail-ability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers 显示文摘 | Barr WH Smith HL Karnes HT | 1990 | Prog Pharmacol Clin Pharmmol1990，8，： | 1 |
| 14 | Precision, accuracy and data acceptance criteria in biopharmaceutical analysis 显示文摘 | KARNES HT MARCH C | 1993 | Pharm Res1993，10，10： | 1 |
| 15 | Recent developments in analytical methodology for 8-hydroxy-20-deoxyguanosine and related compounds 显示文摘 | Peoples MC Karnes HT | 2005 | J Chromatogr B Analyt Technol Biomed Life Sci2005，827，1： | 1 |
| 16 | Precision, accuracy, and data accept- ance criteria in bio - pharmaceutical analysis 显示文摘 | Karnes HT March C | 1993 | Pharm Res1993，10，： | 1 |
| 17 | Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis 显示文摘 | Karnes HT March C | 1993 | Pharm Res1993，10，10： | 1 |
| 18 | Recent developments in analytical methodology for 8 -hydroxy -2' -deoxyguanosine and related eompounds显示文摘 | Peoples MC Karnes HT | 2005 | J Chromatogr B Analyt Technol Biomed Life Sci2005，827，1： | 1 |
| 19 | Precision, accuracy and date acceptance criteria in biopharmaceutical analysis 显示文摘 | Karnes HT March C | 1993 | Pharm Res1993，10，： | 1 |
| 20 | Precision,accuracy,and data acceptance criteria in biopharmaceutical analysis显示文摘 | Karnes HT March C | 1993 | Pharm Res1993，10，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员